Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

51.900
-0.900-1.70%
Volume:13.31M
Turnover:692.26M
Market Cap:213.62B
PE:38.28
High:52.950
Open:52.500
Low:51.550
Close:52.800
52wk High:54.450
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:0.48
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.356
ROE:11.38%
ROA:7.60%
PB:3.80
PE(LYR):38.28
PS:7.74

Loading ...

WuXi Biologics - Wuxi Mashan Site Passes Two-Week FDA Gmp Inspection

THOMSON REUTERS
·
Yesterday

Wuxi Biologics (Cayman) Stock Slips 1.7% in Hong Kong

Dow Jones
·
Yesterday

Wuxi Biologics Posts 18% Top-Line Growth and Strong Margin Expansion in 1H26, Bolstered by Backlog Surge and BioDlink Acquisition

Bulletin Express
·
Sep 22

Wuxi Biologics (Cayman) Stock Climbs 5.3% in Hong Kong

Dow Jones
·
Sep 21

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Stock News
·
Sep 21

Movement Alert|WUXI BIO Rises 3.28% in Regular Trading, Cancellation of Nearly 40 Million Repurchased Shares Boosts Per-Share Value

Market Focus
·
Sep 21

WUXI BIO Cancels 39.82 Million Treasury Shares Purchased Under Buyback Program

Deep News
·
Sep 21

Movement Alert|WUXI BIO Rises 3.09% in Regular Trading, CXO Sector Rallies as Global Pharma Outsourcing Rate Breaks 50%

Market Focus
·
Sep 18

WUXI BIO: Zhisheng Chen Disposes, Long Position Falls to 1.47%

HK Disclosure
·
Sep 17

WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics

Reuters
·
Sep 17

Wuxi Biologics (Cayman) Stock Advances 1.5% in Hong Kong

Dow Jones
·
Sep 16

WuXi Biologics Makes Forbes China ESG 50 List for 2026

Reuters
·
Sep 16

Movement Alert|WUXI BIO Rises 3.21% in Regular Trading, CXO Sector Extends Mid-Year Earnings Rally

Market Focus
·
Sep 16

Wuxi Biologics (Cayman) Stock Advances 4.6% in Hong Kong

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Movement Alert|WUXI BIO Rises 3.06% in Regular Trading, CXO Sector Rallies on Valuation Recovery and Strong Fundamentals

Market Focus
·
Sep 14

Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance

Stock News
·
Sep 14

Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks

Stock News
·
Sep 14

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

Dow Jones
·
Sep 10

Movement Alert|WUXI BIO Falls 3.07% in Regular Trading, Trading at 47.44 HKD

Market Focus
·
Sep 10